News & Events

AAT-AD/PD Focus Meeting 2020 - Advances in Alzheimer's and Parkinson's Therapies

The AAT-AD/PD™ Focus Meeting 2020 in Vienna will for a second year present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders. We'll be happy to welcome you at our booth #13 and discuss your current…

Read more

ABL Expands GMP Viral Vector Manufacturing Capacity with State-of-the-Art Facility Acquisition in Lyon, France

ABL is pleased to announce a strategic acquisition through its wholly-owned subsidiary, ABL Europe, of a 6,500 square meter GMP manufacturing site located in Lyon, France. Read more here

Read more

EBF - ICH M10

We look forward to participating to the upcoming EBF Spring Focus Workshop (in collaboration with the AAPS, CBF and JBF) which will focus on ICH M10 - Public consultation & Industry Feedback, Towards a Science based Global Bioanalytical Guideline. More information at http://springfocus.e-b-f.eu/  

Read more

14th​ International Conference on Alzheimer's and Parkinson's Diseases

AD/PD 2019, the 14th​ International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders, will build on the well-earned reputation of previous AD/PDTM Conferences. The ground breaking series of Alzheimer's and Parkinson's Diseases Conferences attract international medical and scientific professionals worldwide.​​ Meet our team at our booth or during…

Read more

The 5th International Conference on Molecular Neurodegeneration

Working on neurodegeneative disorders? Meet our team at the ICMN 2018 to learn more on our services and assays! Learn more on ICMN 2018 here

Read more